Buy Allogene Therapeutics Inc Stock | ALLO Stock Price & Latest News | Public.com
ALLO

Allogene Therapeutics Inc

$0.00 (0.00%)Today
    View Allogene Therapeutics Inc (ALLO) stock trends here

    About ALLO

    Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell prod...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.18
    -0.35
    -0.53
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.45

    Actual EPS
    Q1 2021

    Stats

    Market Cap$4,78B
    Volume674,78k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$55.00
    1 Year Low$17.43
    Open$33.76
    High$35.73
    Low$33.56

    Buy any stock with any amount of money.

    Download the App
    Download the app